Published in Gene Therapy Weekly, February 23rd, 2006
"Parkinson disease (PD) is a neurodegenerative movement disorder characterized by selective loss of dopaminergic neurons and the presence of Lewy bodies. Alpha-synuclein is a major component of Lewy bodies in sporadic PD, and mutations in alpha-synuclein cause autosomal-dominant hereditary PD."
"Here," wrote W.W. Smith and colleagues, Johns Hopkins University, "we generated A53T mutant alpha-synuclein-inducible PC12 cell lines using the Tet-off regulatory system."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.